CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 555 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 440 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 493 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 427 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 482 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 442 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 528 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 447 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 444 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 438 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 430 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 430 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 441 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 450 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 466 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 435 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 428 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 474 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 417 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 400 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 422 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 458 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 454 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 490 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 425 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy